Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lablanche

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Presse Medicale (Paris, France : 1983)|October 6, 1990
[Treatment of atherosclerosis. New percutaneous intraluminal techniques]J M Lablanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 24, 2006
[Anticoagulation therapy: a stage in the history of percutaneous coronary intervention]J M Lablanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 2, 2003
[Drug eluting stents, a priceless advance!]J M Lablanche
La Revue Du Praticien|February 2, 1989
[Thrombolytic agents]J M Lablanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1997
[Is benefit of open artery only dependent of myocardial viability?]J M Lablanche
Current Medical Research and Opinion|March 28, 2001
Achieving LDL-C target levels: the role of statinsJ M Lablanche
Annales De Cardiologie Et D'Angeiologie|December 30, 1989
[Prospects in the treatment of stenosis of the coronary arteries]J M Lablanche
Acta Medica Scandinavica. Supplementum|January 1, 1979
Pulmonary valve motion in valvular pulmonary stenosis in childhoodC Rey, J M LaBlanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 2000
[Report on interventional coronary cardiology in France. Angiography and Interventional Cardiology Group of the French Society of Cardiology]D Blanchard, J M Lablanche
Annales De Cardiologie Et D'Angeiologie|August 5, 2004
[BRIDGE registry (safety and efficacy registry Bx Cyper stent in the RevascularIzation of patients with siGnificative risk of rEstenosis): protocol description and preliminary results]J-M Lablanche, P Commeau,
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Presse Medicale (Paris, France : 1983)|October 6, 1990
[Treatment of atherosclerosis. New percutaneous intraluminal techniques]J M Lablanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 24, 2006
[Anticoagulation therapy: a stage in the history of percutaneous coronary intervention]J M Lablanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 2, 2003
[Drug eluting stents, a priceless advance!]J M Lablanche
La Revue Du Praticien|February 2, 1989
[Thrombolytic agents]J M Lablanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1997
[Is benefit of open artery only dependent of myocardial viability?]J M Lablanche
Current Medical Research and Opinion|March 28, 2001
Achieving LDL-C target levels: the role of statinsJ M Lablanche
Annales De Cardiologie Et D'Angeiologie|December 30, 1989
[Prospects in the treatment of stenosis of the coronary arteries]J M Lablanche
Acta Medica Scandinavica. Supplementum|January 1, 1979
Pulmonary valve motion in valvular pulmonary stenosis in childhoodC Rey, J M LaBlanche
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 2000
[Report on interventional coronary cardiology in France. Angiography and Interventional Cardiology Group of the French Society of Cardiology]D Blanchard, J M Lablanche
Annales De Cardiologie Et D'Angeiologie|August 5, 2004
[BRIDGE registry (safety and efficacy registry Bx Cyper stent in the RevascularIzation of patients with siGnificative risk of rEstenosis): protocol description and preliminary results]J-M Lablanche, P Commeau,
Pageof 22